COVID-19. Covid-19
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group, in addition to receiving standard medications, use a syrup or nasal spray prepared from the mountain ghaziani plant, which is dried under no
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: Confirmation of coronavirus infection by CT scan of the chest and PCR test Age 20 to 70 years Willingness to cooperate in the study and completion of informed written consent
Exclusion criteria
Exclusion criteria: pregnant women children Elderly (people over 70) People who use mechanical ventilation People undergoing chemotherapy People who receive corticosteroids are excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood oxygen saturation. Timepoint: At the beginning and end of the study on a regular basis. Method of measurement: Pulse oximeter.;Rate of lung involvement. Timepoint: beginning and end of the study. Method of measurement: computed tomography scan. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of breaths. Timepoint: At the beginning and end of the study on a regular basis. Method of measurement: Counting breaths per minute.;Body temperature. Timepoint: At the beginning and end of the study on a regular basis. Method of measurement: thermometer and clinical examination.;Dyspnea. Timepoint: At the beginning and end of the study on a regular basis. Method of measurement: clinical examination.;Cough. Timepoint: At the beginning and end of the study on a regular basis. Method of measurement: clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Amiri
Kermanshah University of Medical Sciences
Outcome results
None listed